Reductive amination in the synthesis of pharmaceuticals

OI Afanasyev, E Kuchuk, DL Usanov… - Chemical reviews, 2019 - ACS Publications
Reductive amination plays a paramount role in pharmaceutical and medicinal chemistry
owing to its synthetic merits and the ubiquitous presence of amines among biologically …

Citalopram versus other anti‐depressive agents for depression

A Cipriani, M Purgato, TA Furukawa… - Cochrane Database …, 2012 - cochranelibrary.com
Background Recent US and UK clinical practice guidelines recommend that second‐
generation antidepressants should be considered amongst the best first‐line options when …

Escitalopram in the treatment of major depressive disorder: a meta-analysis

SH Kennedy, HF Andersen… - Current medical research …, 2009 - Taylor & Francis
Objective: To assess the relative antidepressant efficacy of escitalopram and comparator
antidepressants. Research design and methods: A meta-analysis was performed using …

Escitalopram: a review of its use in the management of major depressive disorder

D Murdoch, SJ Keam - Drugs, 2005 - Springer
Summary Abstract Escitalopram (Cipralex®, Lexapro™), the active S-enantiomer of the
racemic selective serotonin reuptake inhibitor (SSRI) citalopram (RS-citalopram), is a highly …

Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability

E Kirino - Patient preference and adherence, 2012 - Taylor & Francis
Escitalopram (escitalopram oxalate; Cipralex®, Lexapro®) is a selective serotonin reuptake
inhibitor (SSRI) used for the treatment of major depressive disorder (MDD) and anxiety …

Does escitalopram reduce neurotoxicity in major depression?

A Halaris, AM Myint, V Savant, E Meresh, E Lim… - Journal of psychiatric …, 2015 - Elsevier
A pro-inflammatory state and a dysregulation in the tryptophan/kynurenine pathway have
been documented in depression. This study examined whether treatment with the SSRI …

Escitalopram: a review of its use in the management of major depressive disorder in adults

KP Garnock-Jones, PL McCormack - CNS drugs, 2010 - Springer
Escitalopram (escitalopram oxalate; Cipralex®, Lexapro®), a selective serotonin reuptake
inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) …

Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active …

VY Yevtushenko, AI Belous, YG Yevtushenko… - Clinical …, 2007 - Elsevier
Background: The S-enantiomer of citalopram (escitalopram) is the active moiety linked to the
anti-depressant effects associated with citalopram (the racemate). For escitalopram to be …

Efficacy of escitalopram compared to citalopram: a meta-analysis

S Montgomery, T Hansen… - International Journal of …, 2011 - academic.oup.com
The aim of this review was to assess the clinical relevance of the relative antidepressant
efficacy of escitalopram and citalopram by meta-analysis. Studies in major depressive …

Adverse cardiac events in older patients receiving venlafaxine: a population-based study

JM Ho, T Gomes, SE Straus, PC Austin… - The Journal of clinical …, 2014 - psychiatrist.com
Objective: Venlafaxine is a commonly prescribed antidepressant, but whether its
noradrenergic effects impart increased cardiovascular risk is unknown. We sought to …